Tonghua Dongbao Pharmaceutical Co., Ltd.

Symbol: 600867.SS

SHH

9.05

CNY

Market price today

  • 15.9005

    P/E Ratio

  • 5.1549

    PEG Ratio

  • 17.79B

    MRK Cap

  • 0.03%

    DIV Yield

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) Stock Split, History Data

Working capital analysis

In terms of working capital, Tonghua Dongbao Pharmaceutical Co., Ltd. maintains a healthy position. The total current assets of the company are valued at $2816354808. This represents a growth rate of 36.955% compared to the previous year. Breaking down the current assets, the cash and investments are worth $1104204462, exhibiting a growth rate of 40.116% year-on-year. The receivables, another significant portion of the current assets, are valued at $916833140. The year-on-year growth rate for receivables is 77.873%. The inventory, which forms a critical part of the assets, is valued at $705345622. This represents a healthy year-on-year growth of 7.868% On the liabilities side, the company's current liabilities total $520160855. This reflects a growth rate of 220.982% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
1104.20
788.06
865.04
593.38
368.01
355.98
Receavebles
916.83
515.44
707.34
623.67
724.25
677.21
Inventory
705.35
653.90
537.92
537.58
628.76
901.02
Other
34.46
40.55
15.17
17.43
205.61
339.01
Total Current Assets
2816.35
2056.41
2162.46
1922.42
1926.63
2273.23
Acc Payable
115.90
80.86
75.00
68.17
69.15
131.96
Short Term Debt
150.00
21.08
7.89
8.17
125.00
450.00
Other Current Liab
243.78
81.20
193.55
140.01
29.95
69.42
Current Liabilities
520.16
162.05
268.55
208.18
304.85
691.40

Capital Structure

When examining the capital structure of Tonghua Dongbao Pharmaceutical Co., Ltd., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $7897954449. When juxtaposed with the previous year, this marks a growth rate of 12.859%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $467009248. Compared to the prior year, this reflects a growth rate of 133.491%. On the asset side, the cash and equivalent reserves are worth $1073276217. The year-on-year growth of these reserves is 25.058%. The company's common stock, another important asset, holds a value of $1993617453, growing at a rate of -0.003% from the previous year. Finally, the company's retained earnings stand at $3912094091, marking a growth rate of 19.419% year-over-year. These earnings represent the profits that Tonghua Dongbao Pharmaceutical Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$7,897.95

Total liabilities

$467,009,248.00

Long term debt

$0.00

Cash and eqv

$1,073,276,217.00

Goodwill

$0.00

Retained earnings

$3,912,094,091.00

Common stock

$92.45

Enterprise Value

$13.85

Historical dividend key summary

Tonghua Dongbao Pharmaceutical Co., Ltd.'s dividend per share is $0.25, showing the earnings shared with shareholders per share. It has grown by 0.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20240.0000.2500.0000.0000.250
20230.0000.2500.0000.0000.250
20220.0000.3000.0000.2500.550
20210.0000.2100.0000.0000.210
20200.0000.2000.0000.0000.200
20190.0000.2000.0000.0000.200
20180.0000.1670.0000.0000.167
20170.0000.1390.0000.0000.139
20160.0000.1160.0000.0000.116
20150.0000.1050.0000.0000.105
20140.0000.0880.0000.0000.088
20130.0000.0730.0000.0000.073
20120.0000.0730.0000.0000.073
20030.0000.0000.0290.0000.029
20010.0000.0140.0000.0000.014
19960.0000.0000.0320.0000.032

Net earnings per share (EPS)

Tonghua Dongbao Pharmaceutical Co., Ltd. has an EPS of $0.11, which signifies the profit allocated per share of common stock. With a growth rate of -81.667% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
20240.11---0.11
20230.130.120.140.210.60
20220.420.180.110.09090.80
20210.170.160.190.120.64
20200.140.130.10.090.46
20190.130.130.080.060.40
20180.160.130.070.080.44
20170.130.120.140.110.50
20160.09720.09440.110.08330.38
20150.06940.09030.07640.06250.30
20140.04730.03950.04050.03470.16
20130.03950.02890.0421-0.00270.11
20120.02190.02190.0307-0.03790.03
20110.02190.010.17-0.02130.18
20100.02170.03110.02670.03380.11
20090.01580.00060.0249-0.00040.04
20080.00870.01410.012-0.00680.02
20070.00690.01530.00430.00990.04
20060.00350.01070.0078-0.01370.01
20050.00270.00590.0012-0.00110.01
20040.00470.00360.0006-0.0507-0.05
20030.00460.00760.00470.00240.01
20020.00210.00760.00630.00540.03

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) stock split history

Understanding the historical stock splits of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on May 25, 2018 with a ratio of 1.2:1. Throughout its history, the company has undergone 13 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.

DateSplit Ratio
25 May 20181.2:1
06 June 201712:10
02 June 201612:10
18 May 201511:10
22 April 201412:10
24 May 201312:10
08 June 201113:10
11 June 20101.2:1
17 June 200913:10
02 July 19991.2:1
08 May 19971.5:1
02 May 19951.3:1
29 August 19941.2:1

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 0.267.

What is company revenue per share?

The company revenue per share is 0.420.

What are firm earnings per share?

The firm earnings per share is 0.896.

What is Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) ROIC (return on capital)?

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) ROIC (return on capital) is 0.168.

What is dividend per share figure?

The dividend per share is 0.250

What is enterprise plowback ratio?

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 13.850

What is company debt to equity ratio?

The debt to equity ratio is 0.031

What are debt ratio numbers?

The debt ratio is 0.029

What is company price to sales ratio?

The price to sales ratio is 5.976